{
    "Question": "Healthplus.ai CES 2024 product highlight and specification",
    "Summary": "Healthplus.ai\n\nPERISCOPE\n\n- NextGen AI-driven Software as a Medical Device (SaMD)\n- Predicts risk of postoperative bacterial infections\n- Seamless interface with Electronic Health Records and usual HC workflows\n- Re-uses existing data with a powerful AI engine for early identification of patients with high, medium, or low risk of infection\n- Provides a user-friendly dashboard directly into the workflow\n- Re-calibrates and validates to adapt to patient population, protocols, and professionals\n- Integrates with local EHR\n- Negative predictive value of 97+% for low-risk patients\n- AUROC for predicting infections >0.85 for medium-risk patients\n- Connects with potential customers, development partners, and investors at CES 2024",
    "Summary_cn": "Healthplus.ai\n\nPERISCOPE\n\n- 下一代人工智能驅動的醫療設備軟件（SaMD）\n- 預測術後細菌感染的風險\n- 與電子健康記錄和常規衛生保健工作流程無縫接口\n- 利用強大的人工智能引擎重用現有數據，早期識別出高、中、低風險感染的患者\n- 提供直接集成到工作流程的用戶友好的儀表板\n- 重新校準和驗證，以適應患者人群、議定書和專業人士\n- 與當地的電子健康記錄集成\n- 對於低風險患者，負預測值超過97％\n- 對於中風險患者，預測感染的受試者操作特徵（AUROC）大於0.85\n- 在2024年的CES上與潛在客戶、開發合作夥伴和投資者建立聯繫"
}